Achyut Healthcare Ltd.
Achyut Healthcare
₹ 0.00
0.00 (0.00)%
NSE
BSE
Trading
Small-cap - With a market cap of ₹1.27 Cr.
| EX-Date | Purpose |
|---|---|
| 26 05 2022 | Audited Results |
| 03 09 2022 | Inter alia, to consider and approve : 1. To call 27th Annual General Meeting of the Company and decide the time, date, day and venue of the meeting. 2. To consider and approve Notice of 27th Annual General Meeting, Director?s Report for the year ending 31st March, 2022. 3. To approve the appointment of M/s Doshi Doshi & Co. (Firm Reg. No. : 153683W) as Statutory Auditor of the Company. 4. To fix the date of Book Closure of the Company. 5. Any other item with the permission of the Chair and Majority of Directors. |
| 12 11 2022 | Half Yearly Results |
| 21 11 2022 | Preferential Issue of shares & Increase in Authorised Capital |
| 05 01 2023 | Preferential Issue of shares (Revised) |
| 18 03 2023 | Bonus issue & Inter alia, to transact the following business; 1. To consider and recommend bonus issue of equity shares. 2. To fix Record Date for the said bonus issue. 3. To appoint Scrutinizer to Scrutinize the Voting process in fair and transparent manner. 4. To consider and approve notice calling Extra Ordinary General Meeting. 5. Any other Business with the permission of Chair and majority of directors |
| 27 05 2023 | Audited Results |
| 28 08 2023 | A.G.M. & Inter alia, to transact following business:- 1. To call 28th Annual General Meeting of the Company and decide the time, date, day and venue of the meeting. 2. To consider and approve Notice of 28th Annual General Meeting & Director?s Report for the year ending 31st March, 2023. 3. To Appoint Mr. Kamlesh M Shah & Co., PCS as Scrutinizers for the e.voting process of the company?s ensuing AGM to be held as OAVM. 4. To fix the date of Book Closure of the Company. 5. Any other item with the permission of the Chair and Majority of Directors. |
| 04 11 2023 | Half Yearly Results |
| 15 11 2023 | Preferential Issue of shares & Increase in Authorised Capital |
| 19 10 2024 | Half Yearly Results & Stock Split & Bonus issue & Increase in Authorised Capital Inter alia, to transact following business :- 1. To consider and approve the unaudited financial result of the Company for the half year ended on 30th September, 2024. 2. To consider and approve Sub-Division of the face value of equity share subject to necessary approvals. 3. To consider and approve Increase in Authorized Capital of the Company subject to approval of the members; 4. To recommend and approve issue of Bonus shares post sub-division of shares to the equity shareholders of the Company. 5. To consider and approve the related party transaction disclosure under regulation 23 (9) of SEBI (Listing obligations and Disclosure Requirements), 2015 for the half year ended 30th September, 2024. |
| 17 04 2025 | Inter alia, to transact following business: 1. To consider and approve migration of listing/trading of equity shares of the Company from SME Platform of BSE to Main Board of BSE in terms of Chapter IX of SEBI (ICDR) Regulations, 2018 subject to necessary approvals. 2. Any other item with the permission of the Chair and Majority of Directors |
| 29 05 2025 | Audited Results |
| 02 09 2025 | A.G.M. |
| 16 10 2025 | Half Yearly Results |
| 17 01 2026 | Increase in Authorised Capital & Preferential Issue of shares & Quarterly Results |
| 21 01 2026 | Quarterly Results |
No News data available
